Chicago Headache Center & Research Institute
2 clinical trials · Sponsor
◉ Watch Chicago Headache Center & Research Institute
| Record | Firm | Date |
|---|---|---|
| COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study (NCT05724771) | Chicago Headache Center & Research Institute | 2023-01-26 |
| Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies (NCT05503082) | Chicago Headache Center & Research Institute | 2022-09-06 |
Track Chicago Headache Center & Research Institute automatically
Every clearance here is in the API, with alerts when new ones post.